Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Retatrutide for Sale > FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99%
FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99% buy - large image1
FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99% buy - image1
FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99% buy - image2
FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99% buy - image3
FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99% buy - image4
FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99% buy - image5
FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99% buy - image6

FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99%

TDS 5961 Inquiries

Unit Price:

$200-260/G EXW

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Packaging:

vials Cartridge APIs

Price valid (until):

2027-07-15

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Tirzepatide,Semaglutide,TB500,HGH Fragment 176-191,GHK-Cu (Copper Peptide)

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    Items Specifications
    Retatrutide vials 5mg 10mg  12mg  15mg  20mg  22mg  30mg 
    Retatrutide Cartridge 5mg 10mg  12mg  15mg  20mg  22mg  30mg 
    Retatrutide APIs g kg


    Shop FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99%-Detailed Image 1

    Shop FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99%-Detailed Image 2 Shop FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99%-Detailed Image 3 Shop FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99%-Detailed Image 4 Shop FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99%-Detailed Image 5

    Year of Establishment: 2019 | Business Type: Manufactory

    Name: Mark

    WhatsApp:+60 11-2177 6267

    WeChat: Mark601121776267

    Email: wukongceob2b@gmail.com


    Retatrutide (LY3437943) acetate is a triple agonist peptide for the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R).

    Retatrutide acetate inhibits human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643, and 0.775 nM, respectively. It exhibits activity on mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191, and 0.794 nM, respectively.

    In vivo, Retatrutide (LY3437943) acetate engages with GCGR and enhances glucose tolerance in an ipGTT by acting through GIP or GLP-1 receptors. Activation via the glucagon receptor by Retatrutide acetate leads to significant weight reduction and increased energy expenditure. Retatrutide acetate can be utilized in research related to obesity.

    Retatrutide, LY3437943

    CAS#: 2381089-83-2

    Molecular Formula: C221H342N46O68

    Molecular Weight: 4731.33

    Sequence: H-Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

    Appearance: White Powder

    Purity (HPLC): ≥99.0%

    Single Impurity (HPLC): ≤1.0%

    Sodium Content (HPLC): 5.0%-12.0%

    Moisture Content (Karl Fischer): ≤10.0%

    Peptide Content: ≥80.0%

    Storage: Store at 2-8 degrees Celsius in a dry and cool place.

    Packaging: 1g-1kg, plastic bottle

    Intended Use: For scientific research purposes





    Shop FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99%-Detailed Image 6

    Our headquarters is located in the Xiasha Economic Development Zone in Hangzhou, China. Our research team has nearly 20 years of experience in peptide research and development. We have completed international applications for multiple products and have extensive experience in ANDA marketing for complex formulations in the United States, Europe, Japan, and other regions.






    The company is positioned as an international-level peptide delivery platform. It has research bases in China and the United States and adopts international R&D standards to provide customers with one-stop solutions for peptide products. Provide customers with technology development and international filing and registration services for new peptide products, a full set of peptide impurities, and consistency evaluation. At the same time, the company has established a scientific and complete peptide research and development system and a quality assurance system that meets international application requirements to ensure the scientificity and compliance of project research and development.



    Certificates
    • FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99% Certificates 1

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    LY3437943;Retatrutide;GIPR/GLP-1R;Retatrutide/LY3437943/GIPR/GLP-1R;Retaglutide;Retatrutide acetate;LY3437943Retatrutide;Retalutide

    CAS No.:

    2381089-83-2

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Other Chemical Drugs

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,Semaglutide,TB500,HGH Fragment 176-191,GHK-Cu (Copper Peptide)

    Location:

    1-1, Building 19, No. 78, Shengli Road, Xinzhou District, Shangrao City, Jiangxi Province

    Payment Terms:

    100% TT in advance

    Average lead Time:

    7

    Total Employees:

    Above 1000

    Year of Establishment:

    2023

    Certifications:

    GMP,FDA,Semaglutide COA,Tirzepatide COA,Retatrutide COA

    Company Profile

    Many of our products have obtained DMF registration from the US FDA, and our team of peptide experts has extensive experience in peptide research and development. Products have successfully landed in China, the United States, Europe, Japan and other markets. ThinHeal is committed to building an international peptide delivery system and providing customers with one-stop service..
    The company is positioned as an international-level peptide delivery platform. It has research bases in China and the United States and adopts international R&D standards to provide customers with one-stop solutions for peptide products. Provide customers with technology development and international filing and registration services for new peptide products, a full set of peptide impurities, and consistency evaluation. At the same time, the company has established a scientific and complete peptide research and development system and a quality assurance system that meets international application requirements to ensure the scientificity and compliance of project research and development.
    The scientific research team has nearly 20 years of experience in peptide research and development, has completed international applications for multiple varieties, and has rich marketing experience in complex preparations ANDA in the United States, Europe, Japan and other places.

    The company has built an international R&D standard experimental platform of nearly 2,000 square meters, equipped with advanced instruments and equipment such as waters high-performance liquid chromatography, mass spectrometry system, gas chromatograph, freeze dryer, etc. to ensure the scientific and orderly progress of R&D projects.

    Doctors are benevolent, and benevolent people are trustworthy. The sea accepts all rivers, and tolerance is great. ThinHeal Pharma adheres to the concepts of pragmatism, integrity and inclusiveness, actively promotes the development and innovation of the peptide industry, and provides accessible solutions to the majority of patients!

    Core advantages

    1. Complete quality management system: The company has established a quality management system covering the entire life cycle of peptide based on China GMP, 21CFR Part 210, 211, EU cGMP Volume 4, and ICH guideline, providing comprehensive and complete quality assurance for the entire product process.

    2. Mature project management advantages: In terms of project management, the team fully implements the ICH guideline requirements according to customer needs. The team has high-end peptide research and development experience and international application experience to ensure the smooth development of the project.

    3. Solid cGMP management advantages: The team has rich cGMP management experience and implements cGMP management for product transfer, process verification and commercial production according to the requirements of different declaration places (including China, the United States, the European Union, and Japan).

    4. Advantages of cost control management: From peptide synthesis route selection, purification process optimization to full-process quality control, we always put customer interests first and achieve effective cost control while ensuring product quality and regulatory compliance.

     5. Mature process development technology: platform-based peptide process development technology.

    In terms of peptide raw materials: up to 40 peptide synthesis experiences, including but not limited to the synthesis of linear peptides/cyclic peptides/polypeptide products containing multiple disulfide bonds; solid phase/liquid phase peptide synthesis and assembly coupling; peptide modification and polypeptide synthesis Cyclic peptide synthesis.

    Peptide preparations: including process development and quality control of peptide injections, peptide oral sustained-release preparations, and long-acting peptide injections, as well as experience in stability research and scale-up production.



  • Inquiry History
    5961 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.